Walmart will announce its fiscal second-quarter 2027 results on August 20, 2026, before the market opens. Analysts expect earnings per share (EPS) of $0.74 and revenue of $186.8 billion, reflecting year-over-year growth of 5% in revenue and 8.8% in EPS. Despite steady revenue growth, Walmart's operating margin remains around 4.5%, below the hoped-for 5%. The company maintains its long-term growth outlook of 5% revenue growth and high single- to low double-digit EPS growth.
Stocks showed a split reaction Thursday as the Dow and S&P 500 rose with buyers favoring non-tech sectors, while the Nasdaq struggled due to ongoing pressure on AI and memory-chip stocks. The Producer Price Index (PPI) came in hotter than expected, r...
Walmart's stock rose 3% following a Deutsche Bank upgrade to Buy, driven by strong pricing power and accelerating market share in groceries and digital segments. This gain contrasts with a broader retail sector decline, highlighting Walmart's appeal ...
Costco's stock trades at a high valuation of about 46 times trailing earnings, yet investors continue buying due to strong membership loyalty, steady traffic growth, and consistent earnings beats. The company reported a strong fiscal Q4 with revenue ...
Walmart's stock gained 3% following a hotter-than-expected inflation report that shifted investor interest toward retailers selling everyday necessities. While Walmart leads with a 4% gain year-to-date, Costco and Target also rose but at slower rates...
Walmart announced it will cover over 250 prescriptions at no cost to employees starting in 2027, including insulin, inhalers, and diabetes drugs Ozempic and Mounjaro for Type 2 diabetes after prior authorization. This move aims to attract and retain ...
